Schreiber Taylor
Known title: Chief Executive OfficerCIK: 0001601942
Schreiber Taylor's purchase track record
Schreiber Taylor has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 10/7/2024 | STTK | $44K | +12.4% | +15.0% | -11.1% |
| 6/26/2024 | STTK | $50K | -4.2% | -70.7% | +10.2% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| STTK | ▲ Buy | Grant | 25,610 | $28K | 5/12/2026 | View on chart |
| STTK | ▲ Buy | Grant | 25,610 | $22K | 8/25/2025 | View on chart |
| STTK | ▲ Buy | Open Market | 36,500 | $44K | 10/7/2024 | View on chart |
| STTK | ▲ Buy | Open Market | 14,400 | $50K | 6/26/2024 | View on chart |
| STTK | ▲ Buy | Option Exercise | 3,050 | $11K | 6/4/2024 | View on chart |
| STTK | ▲ Buy | Option Exercise | 3,926 | $18K | 1/28/2022 | View on chart |
| STTK | ▲ Buy | Option Exercise | 3,926 | $18K | 11/10/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
UBS initiates coverage on Shattuck Labs with $17 price target
UBS has started covering Shattuck Labs, assigning a price target of $17. This new analyst view comes as the company prepares to present research at UEG Week 2026. The stock is currently trading near its 52-week low, making this fresh institutional attention a notable development for the company.
UBS initiates coverage on Shattuck Labs with $17 price target. UBS has started covering Shattuck Labs, assigning a price target of $17. This new analyst view comes as the company prepares to present research at UEG Week 2026. The stock is currently trading near its 52-week low, making this fresh institutional attention a notable development for the company.